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Introduction
Aluminum phosphide (ALP) is a highly toxic pesticide 
that is used as a rodenticide and insecticide. Its toxic ef-
fects are due to liberation of phosphine gas upon exposure 
to moisture (1-4). This gas can easily be absorbed from 
gastrointestinal and pulmonary tracts or on dermal ab-
sorption (1,2). Phosphine as an oxidant can cause hypoxic 
damage at the cellular level due to binding cytochrome 
oxidase and inhibiting oxidative phosphorylation (4). A 
wide range of symptoms and signs of ALP toxicity are re-
ported including vomiting, diarrhea, cyanosis, pulmonary 
edema, respiratory failure, renal failure, metabolic acido-
sis, hepatic failure, cardiovascular collapse, dizziness and 
death (4,5). Some authors describe hemolysis due to ALP 
toxicity (2). Mortality rate of ALP poisoning is reported 
between 50% to 60% in literature.  
We report a survived 22-year-old male patient who was 
admitted to the emergency department (ED) after a sui-
cidal ingestion of ALP. 
Case presentation
A 22-year-old man was brought to the ED after a suicidal 
ingestion of two tablets of ALP (6 g) and 100 tablets of 
paracetamol. He was fully conscious, mildly anxious, and 
suffered from abdominal pain. He had a blood pressure of 
80/60 mm Hg, a heart rate of 100 beats/min, a respiratory 
rate of 42, and a body temperature of 36.7°C. Heart and 
lungs were normal in auscultation and initial electrocar-
diogram (ECG) taken in ED had no abnormal changes. 
Abdomen was soft without tenderness. Nasogastric tube 
was placed immediately and gastric lavage was performed 
with sunflower oil. The initial arterial blood gas (ABG) 
analysis showed a metabolic acidosis (pH=7.33) and bi-
carbonate 19 mmol/dl. He was treated with sodium bicar-
bonate, 0.9% saline, calcium gluconate, and magnesium 
sulfate. [Glucose, Insulin, Katrium (Potassium)] GIK pro-
tocol was commenced for patient with Glucose, 60 units of 
regular insulin and 40 mEq of potassium in normal saline. 
He was paralyzed, intubated and connected to mechani-
cal ventilator because of acidosis and tachypnea. Due to 
progressive hypotension infusion of 10 µg/min epineph-
rine was added to treatment. N-acetyl cysteine (NAC) was 
commenced. 
Patient was admitted in intensive care unit (ICU). Treat-
ment continued with magnesium sulfate (1 g/6h), calcium 
gluconate (1 g/6h), sodium bicarbonate (50 mmol/h), 
regular insulin (6 unit/2h), hypertonic glucose, and potas-
sium chloride (20 mEq in one liter of 0.9% saline). After 
achieving normal blood pressure, epinephrine infusion 
was discontinued. NAC infusion continued with 70 mg/
kg/4h. In the second day of admission, potassium chlo-
ride (KCL) infusion decreased to 10 mEq in each liter of 
crystalloid and infusion of glucose, insulin, magnesium 
sulfate, and calcium gluconate was discontinued. Hydro-
cortisone (200 mg/12h) started. In third day, NAC infu-
sion changed to oral administration and continued with 
Case Report
Volume 1, Issue 2, 2015, p. 67-68
Successful outcome in managing of aluminum phosphide 
poisoning
© 2015 The Author(s). Published by Kerman University of Medical Sciences. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Samad Shams Vahdati1, Reza Shahab Moghadam1, Zahra Vandrajabpour2*, Pouya Paknejad1, 
 Shahrad Tajoddini3
1Department of Emergency Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
2Medical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran
3Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran
Received: 9 October 2014
Accepted: 2 February 2015
Published online: 21 February 2015
*Corresponding author: Zahra 
Vandrajabpour, Tabriz University of 
Medical Sciences, Tabriz, Iran.
Email: sshamsv@yahoo.com
Competing interests: The authors 
declare that no competing interests 
exist.
Funding information: There is none to 
be declared.
Abstract
Aluminum phosphide  (ALP) is a potent lethal substance, that use for agriculture 
purpose, as a pesticide. this substance may use for suicide, and it will kill the patient 
rapidly. we want to report a patient who use ALP for suicide purpose and was managed 
quickly in the emergency department and he became alive.
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600 mg/4h. Patient was extubated and hydrocortisone 
decreased to 100 mg/12h. Because of patient’s abdominal 
pain, an upper gastrointestinal endoscopy was performed 
which was reported normal. 
In the fifth day, the patient was admitted to psychiatry 
ward with no morbidity due to ALP toxicity.
    
Discussion
ALP is a highly toxic pesticide that is used widely in agri-
culture since 1940s (1,4). It is cheap and easily achievable 
in countries, such as Iran and India (4). ALP poisoning is 
common either as an accidental intoxication or for sui-
cidal reasons and is a serious public health problem in de-
veloping countries, mainly in Northern India where this 
intoxication is the main reason of poisoning (3). Because 
of high toxicity and no existence of effective antidote, ALP 
poisoning has a high mortality rate (2,5).
 After exposure to moisture, ALP releases phosphine gas 
which is the active toxic component (1,4,5). Each three 
grams tablet can release one gram phosphine (4). Phos-
phine gas could be absorbed from the respiratory system, 
gastrointestinal tract or on dermal absorption (1,5). By 
inhibiting mitochondrial cytochrome oxidase, phosphine 
can inhibit the oxidative respiration by 70% and can also 
make oxidative damage by producing oxidant free radicals 
(1,2,4). Clinical manifestations include various signs and 
symptoms. Nausea, vomiting, abdominal pain, diarrhea, 
palpitation, dizziness and altered consciousness are com-
mon symptoms (4). Hypotension, tachycardia, severe car-
diac arrhythmias, tachypnea, severe metabolic acidosis, 
acute renal failure, tubular necrosis, hepatic failure, and 
hemorrhage are some of common complications of ALP 
poisoning (4). Death, in most times, is due to arrhythmia, 
cardiopulmonary collapse or metabolic acidosis (2). The 
lethal dose of phosphine for a 70 kg person is 150-500 mg 
(2,4) and survival is unlikely after ingestion of 1500 mg of 
ALP (1,3).
Due to its high toxicity, ALP poisoning should be treated 
as soon as possible (5). There is no antidote and treatment 
is conservative (2,5). The first and the most important 
step for successful treatment is an early resuscitation of 
shock (4). Central vein pressure (CVP) should be kept at 
around 12-14 cm of water (4). Hydrocortisone 200 mg 
each 2-4 hours could be helpful to combat shock and pre-
vent the patient from acute respiratory distress syndrome 
(ARDS) (4).
Potassium permanganate oxidizes phosphine to non-toxic 
phosphate and gastric lavage with potassium permanga-
nate (1:10,000) can reduce phosphine absorption (4,5). 
Although administration of activated charcoal is contro-
versial (5,6) but the use of approximately 100 g of charcoal 
within the first hour could be useful to reduce absorption 
(4,5). In situations like our case that potassium permanga-
nate is not achievable immediately; gastric lavage with co-
conut oil or any other vegetable oil can reduce phosphine 
release and absorption. 
Intravenous sodium bicarbonate for aggressive correction 
of metabolic acidosis could improve patient outcome (5). 
Serum bicarbonate level less than 15 mEq/L requires so-
dium bicarbonate intravenously administration (4). Hy-
pomagnesaemia is common (3,4). Many studies described 
the potential role of magnesium sulfate in reducing the 
fatal outcome in acute ALP poisoning, but at present, the 
routine use of magnesium intravenous administration is 
controversial since some literature showed hypermagne-
semia in some cases (5). The NAC as an effective treat-
ment in ALP poisoning, can prevent hepatic complica-
tions and delays mortality latency time (4).
In our case early arrival, aggressive resuscitation and early 
prevention of phosphine absorption by using vegetable oil 
were important factors for a successful outcome. 
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